Recent Publications

A sample of our research papers. 

Ades PA, Keteyian SJ, Wright JS, Hamm LF, Lui K, Newlin K, Shepard DS, Thomas RJ. Increasing Cardiac rehabilitation participation from 20% to 70%: a road map from the million hearts cardiac rehabilitation collaborative. Mayo Clin Proc. 2017;92(2):234-242.

Althoff RR, Ametti M, Bertmann F. The role of food insecurity in developmental psychopathology. Prev Med. 2016;92:106-109.

Dittus KL, Lakoski SG, Savage PD, Kokinda N, Toth M, Stevens D, Woods K, O'Brien P, Ades PA. Exercise-based oncology rehabilitation: leveraging the cardiac rehabilitation model. J Cardiopulm Rehabil Prev. 2015;35(2):130-139.

Gaalema DE, Savage PD, Rengo JL, Cutler AY, Elliott RJ, Priest JS, Higgins ST, Ades PA. Patient characteristics predictive of cardiac rehabilitation adherence. J Cardiopulm Rehabil Prev. 2017;37(2):103-110.

Hart V, Sprague BL, Lakoski SG, Hampton JM, Newcomb PA, Gangnon RE, Trentham-Dietz A. Trends in health-related quality of life after a diagnosis of ductal carcinoma in situ. J Clin Oncol. 2016;34(12):1323-1329.

Higgins ST, Heil SH. Continuing efforts to improve cessation outcomes with pregnant cigarette smokers. Addiction. 2015;110(4):690-692.

Hitchman SC, Pearson JL, Villanti AC. The need for more nuance in headline adult cigarette smoking prevalence estimates. Addiction. 2017.

Phillips JK, King SE, Bernstein IM, Skelly JM, Higgins ST. Associations of maternal obesity and smoking status with perinatal outcomes. J Matern Fetal Neonatal Med. 2017:1-17.

Sigmon SC. The untapped potential of office-based buprenorphine treatment. JAMA Psychiatry. 2015;72(4):395-396.


Our Center of Biomedical Research Excellence (COBRE) project is funded by the NIH’s National Institute on General Medical Sciences (NIGMS). The project focuses on investigating relationships between personal behaviors and risk for chronic disease and premature death. Unhealthy personal behaviors (e.g., substance abuse, physical inactivity) account for 40% of premature deaths in the U.S. annually and substantially increase healthcare costs and health disparities.

There is a tremendous need for (a) greater scientific understanding of the mechanisms underpinning vulnerability to these risk behaviors and (b) more effective interventions to promote behavior change.

We approach these challenges using the concepts, principles, and methods of behavioral economics and behavioral pharmacology.  This effort involves key interdisciplinary collaborations (a) across multiple academic departments and colleges within UVM, (b) with key Vermont community healthcare leaders, and (c) with other universities, including Brown University and University of Kentucky.

                                           Image of Thomas Ahern     Image of Andrea Villanti           Kurti_Allison (1)         
Longden            Brady
Click here to meet our project directors and learn about their research. 

Specific Aims

Aim 1

This COBRE establishes the cores necessary to develop and sustain a vibrant interdisciplinary center of research excellence.  Goals of this aim include providing (a) an Administrative Core that provides leadership, organizational structure, intellectual infrastructure (e.g., seminar series, annual national conference), a mentoring plan, fiscal management, and strategic planning for fiscal support beyond COBRE funding; (b) a Behavioral Economics and Intervention Sciences Core that supports intervention development and evaluation, econometric modeling of cost effectiveness, and the study of health-related decision making and its neurobiological underpinnings, and (c) a Collaboration, Dissemination, and Education Core to facilitate those key missions. 

Aim 2

This COBRE supports the selection and career development of excellent junior faculty Project Directors (PDs) who are the nucleus of the center. This project brings together an interdisciplinary group of accomplished senior scientists, promising junior investigators, and distinguished advisors and collaborators to work closely together as a center of excellence in an area of clinical research that is vitally important to the U.S. public health.